LEAD MODEL 300
Report
- Report Number
- 1644487-2025-10997
- Event Type
- Malfunction
- Date Received
- December 23, 2025
- Date of Event
- November 25, 2025
- Report Date
- December 23, 2025
- Manufacturer
- HOUSTON
- Product Code
- LYJ
- PMA / PMN Number
- P970003
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- 003
Narratives
LIVANOVA USA, INC. SUBMITS THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION, BASED ON INFORMATION THAT LIVANOVA HAS OBTAINED, BUT MAY NOT HAVE BEEN ABLE TO INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION, OR A CONCLUSION BY FDA OR ANYONE ELSE, THAT THE DEVICE, LIVANOVA, OR LIVANOVA'S EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY "DEFECTS¿ OR "MALFUNCTIONS¿. THESE WORDS ARE INCORPORATED INTO THE FDA 3500A MEDWATCH FORM BY THE FDA, AND LIVANOVA OBJECTS TO THEIR USE.
IT WAS REPORTED THAT THE PATIENT HAD BEEN HOSPITALIZED AS THE PATIENT HAD BEEN EXPERIENCING SEIZURES FOR TWO DAYS. THE PHYSICIANS AT HOSPITAL STATE THAT THE PATIENT IS POST ICTAL BUT MOTHER BELIEVES HE IS STILL HAVING THE SEIZURE. THE DEVICE WAS UNABLE TO BE INTERROGATED DUE TO LACK OF AVAILABILITY FROM THE NEUROLOGIST. THE MOTHER ALSO REPORTS THAT IN ADDITION TO THE INCREASE IN SEIZURES CONDITION, THE PATIENT WAS NOT ABLE TO SPEAK, NOR WERE THEY ABLE TO MOVE THEIR LEGS. ASSOCIATION TO VNS THERAPY FOR THESE EVENTS HAS NOT BEEN DETERMINED TO DATE. THREE GOOD FAITH ATTEMPTS HAVE BEEN MADE TO THE PHYSICIAN FOR ADDITIONAL INFORMATION BUT NO RESPONSE HAS BEEN RECEIVED TO DATE. NO OTHER RELEVANT INFORMATION HAS BEEN RECEIVED TO DATE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2381481 | LEAD MODEL 300 | LEAD | LYJ | HOUSTON | 300-20 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 48 YR | Male | Other| H |